summari morn report result came
ahead expect rais outlook key
messag today call compani make progress
turnaround expect deliv ex-fx revenu growth
in-lin weight averag market growth rate wamgr
begin versu progress
evid deliv day-adjust ex-fx organ growth
y/i ahead estim y/i
level report y/i stack two-year basi
zbh growth acceler rel sequenti
quarter believ zbh turnaround six-month sooner
anticip bode well growth result
rais revenu estim y/i
organ ep y/i expect
deliv sequenti improv underli growth
organ versu level versu
level base ep estim
deliv beat revenu ep
better estim report revenu
y/i y/i ex-fx came
estim consensu ep
y/i better estim
better consensu forecast revenu ep
guidanc provid manag anticip similar
perform also partial sell day
impact estim headwind adjust
fx sell day impact report organ sale growth
y/i came ahead estim overal
better-than-expect top-lin growth gross margin drove
ep beat rel estim
continu page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort non-recur item
compani data secur llc estim reuter
continu previou page
zbh top-lin perform driven knee set sport extrem trauma
focu area compani segment beat rel estim driven
set beat knee beat off-set hip miss spine craniomaxillofaci
cmf miss dental miss miss worth note clear
focu knee largest report segment focus rosa tka
total knee arthroplasti launch also identifi set area focu ad resourc
 dollar build special sale forc order drive greater growth ahead
area knee set perform well indic manag initi gain
initi traction notabl rosa key focu call math estim
compani place approxim system quarter initi feedback limit launch
good believ could posit compani go competit busi
current model placement rosa tka system year geographi beat
rel estim driven europ middl east africa emea well
asiapacif total beat off-set america miss
rais outlook expect achiev wamgr growth rate begin
six month ahead plan compani look deliv organ top-lin growth
prior includ fx headwind rang prior
impli guidanc repres acceler versu level
expect fx headwind greater versu expect benefit addit sell day
mostli impact note sell day impact full year look
 continu expect gross margin slightli higher versu year ago higher
versu gross margin higher due anticip refund prior
period medic devic excis tax expect lower effect tax rate full year
look reinvest fund busi net-net look deliv ep
higher low-end versu prior outlook
segment result stack follow zbh result rel estim driven
set knee hip spine cmf dental came expect sale
growth repres y/i ex-fx rate adjust impact sell day
estim sell day neg impact growth approxim
segment zbh result stack follow
knee adjust sale growth sequenti y/i knee sale
versu compar estim result driven
sequenti acceler america europ middl east africa emea off-set
deceler asiapacif varianc rel estim came intern
america rel in-lin overal knee price slightli wors sequenti versu
well within y/i pace declin seen past sever quarter knee volum
improv sequenti versu expect drive growth full
portfolio knee product persona famili knee rosa tka total knee arthroplasti
applic begin full launch model growth growth versu
rosa launch particular focu manag highlight key featur call includ
ct pre-op plan less radiat exposur major disrupt surgic flow
accuraci due dynam track featur recal note last call placement
strategi first focu platinum account highest volum account
follow gold account share along competitor follow new account
key goal drive procedur growth thu make financ option avail
custom need manag expect drive growth knee driven first mix shift
robot cementless revis competit account convers
hip adjust sale growth sequenti y/i hip sale
versu compar estim result driven
sequenti deceler asiapacif emea off-set improv
america varianc rel estim broad-bas look forward like
grow knee busi expens hip busi appear overal hip growth
market growth rang hip price slightli lower sequenti versu
along volum versu worth note begun
see pull hip mako platform see traction hip cup
set adjust sale growth sequenti y/i sport medicin
extrem trauma set sale versu compar
estim set remain attract market price versu
volum versu improv quarter manag note
call set area focu alloc addit resourc believ upper extrem
shoulder especi stemless area focu within set launch sidu stemless
shoulder last year appear improv execut segment
challeng past like benefit improv suppli level well
spine craniomaxillofaci cmf adjust sale growth sequenti
y/i spine cmf sale versu compar
estim spine cmf price versu volum versu
wors quarter manag note call see final impact
sale forc integr dis-synergi spine plan launch rosa one spine platform
along walter bionic arm manag believ drive growth spine
note rosa spine delay compani work instrument integr
focus manufactur rosa tk built line rosa spine brain
elsewher segment believ compani like continu see uptak cmf thorac
product recal manag previous note expect activ portfolio
manag spine given attract bucket growth minim invas surgeri
robot cervic disc
dental adjust sale growth sequenti y/i dental sale
versu compar estim dental price
versu volum versu improv result
sequenti improv manag highlight progress dental busi call
work new market strategi within dental busi appear make progress
driven portfolio realign sale reorgan certain geographi alloc greater
resourc dental busi give chanc turnaround initi look get
price target
price target base approxim cash ep estim risk thesi
includ increas invest slower procedur volum growth price pressur disrupt
integr biomet
zimmer biomet share trade roughli discount large-cap med-tech peer group believ
discount narrow compani benefit leadership new commercially-driven
ceo bryan hanson oper issu resolv pipelin begin fulli
warsaw indiana-bas zimmer biomet hold one world largest orthoped implant
manufactur compani global market leader billion reconstruct orthoped
implant busi hip knee implant togeth account roughli revenu
compani report sale billion
